Roche’s Hemlibra Battles Fierce Competition Amid Rating Hold by Mark Eisenberg 17.06.2024 Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...